Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).

Saved in:
Bibliographic Details
Title: Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).
Authors: Buechel ME; Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Section of Gynecologic Oncology, Oklahoma City, OK, United States of America. Electronic address: MEBuechel@gmail.com., Enserro D; NRG Oncology SDMC, CTD Division, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States of America. Electronic address: enserrod@nrgoncology.org., Burger RA; University of Pennsylvania, Philadelphia, PA, United States of America. Electronic address: Robert.Burger@uphs.upenn.edu., Brady MF; NRG Oncology SDMC, CTD Division, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States of America. Electronic address: bradym@nrgoncology.org., Wade K; Oschner Medical Center, New Orleans, LA, United States of America. Electronic address: katrina.wade@ochsner.org., Secord AA; Duke University, Division of Gynecologic Oncology, Durham, NC, United States of America. Electronic address: angeles.secord@duke.edu., Nixon AB; Duke University, Division of Medical Oncology, Durham, NC, United States of America. Electronic address: anixon@duke.edu., Mirniaharikandehei S; University of Oklahoma, Department of Electrical and Computer Engineering, Norman, OK, United States of America. Electronic address: snmirna@ou.edu., Liu H; University of Oklahoma, Department of Electrical and Computer Engineering, Norman, OK, United States of America. Electronic address: liu@ou.edu., Zheng B; University of Oklahoma, Department of Electrical and Computer Engineering, Norman, OK, United States of America. Electronic address: bin.zheng-1@ou.edu., O'Malley DM; James Cancer Center at the Ohio State University, Columbus, OH, United States of America. Electronic address: omalley.46@osu.edu., Gray H; University of Washington, Seattle, WA, United States of America. Electronic address: hgray@uw.edu., Tewari KS; University of California, Irvine, CA, , United States of America. Electronic address: ktewari@uci.edu., Mannel RS; Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Section of Gynecologic Oncology, Oklahoma City, OK, United States of America. Electronic address: Robert-Mannel@ouhsc.edu., Birrer MJ; University of Alabama, Birmingham, AL, United States of America. Electronic address: mbirrer@uabmc.edu., Moore KN; Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Section of Gynecologic Oncology, Oklahoma City, OK, United States of America. Electronic address: Kathleen-Moore@ouhsc.edu.
Source: Gynecologic oncology [Gynecol Oncol] 2021 May; Vol. 161 (2), pp. 382-388. Date of Electronic Publication: 2021 Mar 10.
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1095-6859
DOI:10.1016/j.ygyno.2021.02.032